美国在COVID-19后对新疫苗开发和虚假信息的看法
Gillian K SteelFisher1, Mary G Findling1, Hannah L Caporello1
1Gillian K. SteelFisher, PhD, MSc, is Principal Research Scientist and Director; Mary G. Findling, PhD, ScM, is Managing Director; and Hannah L. Caporello was Senior Research Projects Manager; all at the Harvard Opinion Research Program, Department of Health Policy and Management, Harvard T.H. Chan School of Public Health, Boston, MA. Alyssa Boyea, MPH, CPH, is Director, Infectious Disease Preparedness, Association of State and Territorial Health Officials. Arlington, VA. Laura Espino is Program Director, National Public Health Information Coalition, Canton, GA. Jazmyne Sutton, PhD, is Research Director, SSRS, Glen Mills, PA.
大多数美国成年人积极看待疫苗的研发,承认其在保护弱势群体中的作用. 然而,公共卫生领导人必须解决有关错误疫苗信息的担忧,并在沟通新疫苗时承认潜在的风险.
科学领域:
- 公共卫生 公共卫生
- 疫苗学 疫苗学 疫苗学
- 卫生沟通健康沟通
背景情况:
- 对于公共卫生倡议来说,公众对疫苗开发的看法至关重要.
- 随着COVID-19的流行,公众对疫苗创新和错误信息的看法受到影响.
- 了解公众对疫苗的态度对于有效的健康战略至关重要.
研究的目的:
- 为了检查美国成年人对疫苗开发的看法.
- 调查公众对传播虚假疫苗信息的认识和信仰.
- 为公众健康沟通策略提供有关疫苗的信息.
主要方法:
- 全国代表性调查对1632名美国成年人进行.
- 对疫苗开发和虚假疫苗信息的流行情况的评估意见.
- 对错误信息的感知来源和性质进行了分析.
主要成果:
- 81%的成年人积极看待疫苗开发,理由是保护弱势群体和预防严重疾病.
- 78%的人认为虚假疫苗信息的传播是一个主要问题.
- 67%的人说他们遇到了错误的疫苗信息,有些人误解有益的信息是有害的.
结论:
- 公共卫生领导人可以利用公众对疫苗开发的积极情绪.
- 沟通策略应该承认疫苗的风险,并避免疏远分享错误信息的个人.
- 解决疫苗所感知的益处和危害的细微差别对于公众的信任至关重要.
更多相关视频
08:41Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
Published on: November 5, 2021
06:08Author Spotlight: A Pseudotype Virus System for Assessing Omicron Subvariants and Neutralizing Antibodies in SARS-CoV-2 Research
Published on: September 8, 2023
相关概念视频
Vaccinations
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Microorganisms in Medicine and Therapeutics
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Viral Recombination
Cross-reactivity
